Genetic testing aims to improve drug satisfaction in underserved communities
NCT ID NCT05141019
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving patients genetic test results early can help doctors choose better medications. About 492 adults with at least three prescriptions will be randomly assigned to get immediate or delayed genetic testing. The goal is to see if this approach improves how satisfied patients feel with their medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pharmacogenetic testing
- What this could lead to
- If successful, this could show that preemptive genetic testing helps personalize medications and improve patient satisfaction, especially in underserved groups.
- What could go wrong
- This is an early-stage feasibility study with 492 participants, so results may not apply broadly. The main outcome is patient satisfaction, not clinical health improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOGENETIC TESTING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UF Health at the University of Florida
Gainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.